Detalhe da pesquisa
1.
Modeling Rett Syndrome Using TALEN-Edited MECP2 Mutant Cynomolgus Monkeys.
Cell
; 169(5): 945-955.e10, 2017 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28525759
2.
Impact of tocilizumab on anti-CD19 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia.
Cancer
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578977
3.
Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL.
Blood
; 139(23): 3376-3386, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338773
4.
Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment.
Cancer Immunol Immunother
; 72(11): 3739-3753, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707586
5.
Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Chinese experience.
Haematologica
; 108(8): 2011-2028, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794504
6.
Sirt1 Protects Subventricular Zone-Derived Neural Stem Cells from DNA Double-Strand Breaks and Contributes to Olfactory Function Maintenance in Aging Mice.
Stem Cells
; 40(5): 493-507, 2022 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349711
7.
Prognostic impact of peripheral eosinophil counts in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy.
Cytotherapy
; 25(6): 573-577, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456447
8.
FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.
Blood
; 135(17): 1472-1483, 2020 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315388
9.
Harnessing A3G for efficient and selective C-to-T conversion at C-rich sequences.
BMC Biol
; 19(1): 34, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602235
10.
Dnmt3a is downregulated by Stat5a and mediates G0/G1 arrest by suppressing the miR-17-5p/Cdkn1a axis in Jak2V617F cells.
BMC Cancer
; 21(1): 1213, 2021 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773997
11.
DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells.
Adv Exp Med Biol
; 1143: 147-171, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338819
12.
KU70 Inhibition Impairs Both Non-Homologous End Joining and Homologous Recombination DNA Damage Repair Through SHP-1 Induced Dephosphorylation of SIRT1 in T-Cell Acute Lymphoblastic Leukemia (T-ALL) [corrected].
Cell Physiol Biochem
; 49(6): 2111-2123, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30273928
13.
SIRT1 Involved in the Regulation of Alternative Splicing Affects the DNA Damage Response in Neural Stem Cells.
Cell Physiol Biochem
; 48(2): 657-669, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025390
14.
Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi.
Tumour Biol
; 37(1): 531-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26227222
15.
Concise reviews: Characteristics and potential applications of human dental tissue-derived mesenchymal stem cells.
Stem Cells
; 33(3): 627-38, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25447379
16.
ß-Catenin overexpression is associated with gefitinib resistance in non-small cell lung cancer cells.
Pulm Pharmacol Ther
; 28(1): 41-48, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23707949
17.
Immune-related chemotactic factors were found in acute coronary syndromes by bioinformatics.
Mol Biol Rep
; 41(7): 4389-95, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24599781
18.
Serine and Arginine-Rich Splicing Factor 3 Promotes the Activation of Quiescent Mouse Neural Stem Cells.
Stem Cells Dev
; 33(3-4): 79-88, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38115601
19.
Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-ß signaling.
Front Med
; 18(1): 128-146, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870681
20.
Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy.
Cancer Med
; 13(6): e6991, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506226